Landos Biopharma Inc.

NASDAQ: LABP · Real-Time Price · USD
22.93
0.13 (0.57%)
At close: May 23, 2024, 10:00 PM

Landos Biopharma Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.05 -0.53 -5.05
PEG Ratio
0.02 0.84 -0.19
PS Ratio
n/a n/a 10.73
PB Ratio
0.72 0.51 2.53
P/FCF Ratio
-1.12 -0.44 -7.03
P/OCF Ratio
-1.12 -0.44 -7.14
OCF/S Ratio
n/a n/a -1.5
Debt / Equity Ratio
n/a n/a n/a
Quick Ratio
6.09 7.39 5.55
Current Ratio
6.09 7.39 5.55
Asset Turnover
n/a n/a 0.19
Interest Coverage
n/a n/a n/a
Return on Equity
-0.69 -0.97 -0.5
Return on Assets
-0.58 -0.84 -0.41
Return on Invested Capital
-0.71 -1 -0.51
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
Gross Profit Margin
n/a n/a 0.99
Net Profit Margin
n/a n/a -2.12
Pretax Profit Margin
n/a n/a -2.13
Operating Profit Margin
n/a n/a -2.16
FCF Margin
n/a n/a n/a
EBITDA Margin
n/a n/a -2.16